Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
Storr M, Patel K, Brand S, Göke B, Lutz B, Buckley N, Massa F, Sibaev A, Yüce B, Zhang H, Emmerdinger D, Keenan C, Sharkey K. Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 2008; 86:925-36.
May 21, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
May 21, 2008
J Mol Med 2008; 86:925-36
Storr Martin A, Patel Kamala D, Brand Stephan, Göke Burkhard, Lutz Beat, Buckley Nancy E, Massa Federico, Sibaev Andrei, Yüce Birol, Zhang Hong, Emmerdinger Dominik, Keenan Catherine M, Sharkey Keith A
more
